Sewon Lee1, Yan Yang1, Miles A Tanner1, Min Li1, Michael A Hill1,2. 1. Dalton Cardiovascular Research Center, University of Missouri-Columbia, MO 65211. 2. Department of Medical Pharmacology & Physiology, University of Missouri-Columbia, MO 65211.
Abstract
OBJECTIVES: Kv7 channels are considered important regulators of vascular smooth muscle contractility. The present study aimed to examine the hypotheses that (i) Kv7 channels are present in mouse cerebral and coronary arteries and regulate vascular reactivity and (ii) regional differences exist in the activity of these channels. METHODS AND RESULTS: PCR confirmed that basilar, Circle of Willis and LAD arteries express predominantly Kv7.1 and 7.4. Western blot analysis, however, showed greater Kv7.4 protein levels in the cerebral vessels. Relaxation to the Kv7 channel activator, retigabine (1-50 μM) was significantly greater in the basilar artery compared to the LAD artery. Similarly, the Kv7 channel inhibitor, linopirdine (10 μM) caused a stronger contraction of the basilar artery. Furthermore, pre-incubation with linopirdine reduced forskolin (cAMP activator)-induced vasorelaxation in basilar while not altering forskolin-induced vasorelaxation of the LAD, suggesting that Kv7 channels play a more prominent role in the cerebral than in the coronary circulation. Consistent with the vessel data, whole cell Kv7 currents in cerebral VSMCs were potentiated by retigabine and inhibited by linopirdine, while these responses were blunted in coronary VSMCs. CONCLUSIONS: This study provides evidence that mouse Kv7 channels may contribute differently to regulating the functional properties of cerebral and coronary arteries. Such heterogeneity has important implications for developing novel therapeutics for cardiovascular dysfunction.
OBJECTIVES: Kv7 channels are considered important regulators of vascular smooth muscle contractility. The present study aimed to examine the hypotheses that (i) Kv7 channels are present in mouse cerebral and coronary arteries and regulate vascular reactivity and (ii) regional differences exist in the activity of these channels. METHODS AND RESULTS: PCR confirmed that basilar, Circle of Willis and LAD arteries express predominantly Kv7.1 and 7.4. Western blot analysis, however, showed greater Kv7.4 protein levels in the cerebral vessels. Relaxation to the Kv7 channel activator, retigabine (1-50 μM) was significantly greater in the basilar artery compared to the LAD artery. Similarly, the Kv7 channel inhibitor, linopirdine (10 μM) caused a stronger contraction of the basilar artery. Furthermore, pre-incubation with linopirdine reduced forskolin (cAMP activator)-induced vasorelaxation in basilar while not altering forskolin-induced vasorelaxation of the LAD, suggesting that Kv7 channels play a more prominent role in the cerebral than in the coronary circulation. Consistent with the vessel data, whole cell Kv7 currents in cerebral VSMCs were potentiated by retigabine and inhibited by linopirdine, while these responses were blunted in coronary VSMCs. CONCLUSIONS: This study provides evidence that mouse Kv7 channels may contribute differently to regulating the functional properties of cerebral and coronary arteries. Such heterogeneity has important implications for developing novel therapeutics for cardiovascular dysfunction.
Authors: George A Gutman; K George Chandy; Stephan Grissmer; Michel Lazdunski; David McKinnon; Luis A Pardo; Gail A Robertson; Bernardo Rudy; Michael C Sanguinetti; Walter Stühmer; Xiaoliang Wang Journal: Pharmacol Rev Date: 2005-12 Impact factor: 25.468
Authors: Yan Yang; Yoshiro Sohma; Zahra Nourian; Srikanth R Ella; Min Li; Aaron Stupica; Ronald J Korthuis; Michael J Davis; Andrew P Braun; Michael A Hill Journal: J Physiol Date: 2013-01-07 Impact factor: 5.182
Authors: Preet S Chadha; Friederike Zunke; Alison J Davis; Thomas A Jepps; Joannes T M Linders; Michael Schwake; Rob Towart; Iain A Greenwood Journal: Br J Pharmacol Date: 2012-06 Impact factor: 8.739
Authors: S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood Journal: Br J Pharmacol Date: 2007-05-21 Impact factor: 8.739
Authors: Anne Schenzer; Thomas Friedrich; Michael Pusch; Paul Saftig; Thomas J Jentsch; Joachim Grötzinger; Michael Schwake Journal: J Neurosci Date: 2005-05-18 Impact factor: 6.167
Authors: Adam G Goodwill; Jillian N Noblet; Daniel Sassoon; Lijuan Fu; Ghassan S Kassab; Luke Schepers; B Paul Herring; Trey S Rottgen; Johnathan D Tune; Gregory M Dick Journal: Basic Res Cardiol Date: 2016-08-05 Impact factor: 17.165
Authors: Kwangseok Hong; Guiling Zhao; Zhongkui Hong; Zhe Sun; Yan Yang; Philip S Clifford; Michael J Davis; Gerald A Meininger; Michael A Hill Journal: J Physiol Date: 2016-10-13 Impact factor: 5.182
Authors: Adam G Goodwill; Lijuan Fu; Jillian N Noblet; Eli D Casalini; Daniel Sassoon; Zachary C Berwick; Ghassan S Kassab; Johnathan D Tune; Gregory M Dick Journal: Am J Physiol Heart Circ Physiol Date: 2016-01-29 Impact factor: 4.733
Authors: Vincenzo Barrese; Jennifer B Stott; Hericka B Figueiredo; Aisah A Aubdool; Adrian J Hobbs; Thomas A Jepps; Alister J McNeish; Iain A Greenwood Journal: Hypertension Date: 2018-04-23 Impact factor: 10.190